Wealthspring Capital’s Translational Development Acquisition Corp TDAC Stock Holding History
Bought
Maintained
Sold
Other funds holding TDAC
LA
KC
MF
WAM
MC
LP
TCM
AIMCA
PAMP
PMAM
Wealthspring Capital's TDAC Position: Q2 2026 in Review
Wealthspring Capital sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 204,690 shares — an estimated $2.16M sold.
Wealthspring Capital first reported a position in TDAC in Q2 2025 and held it in 4 quarters. The position peaked at $2.17M in Q4 2025. 29 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.
- Wealthspring Capital reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
- Wealthspring Capital sold 204,690 Translational Development Acquisition Corp shares in Q2 2026, an estimated $2.16M.
- Wealthspring Capital first reported a position in Translational Development Acquisition Corp in Q2 2025 and held it in 4 quarters.
- Wealthspring Capital's Translational Development Acquisition Corp position peaked at $2.17M in Q4 2025.
- 29 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.
Based on Wealthspring Capital's 13F filing for Q2 2026, filed 15 Jul 2026.